Jiangsu Kanion Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of June 2025: 0.29%

Jiangsu Kanion Pharmaceutical Co Ltd (600557) has an Asset Resilience Ratio of 0.29% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥20.00 Million
≈ $2.93 Million USD Cash + Short-term Investments

Total Assets

CN¥6.83 Billion
≈ $999.94 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how Jiangsu Kanion Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Jiangsu Kanion Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Jiangsu Kanion Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600557 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥20.00 Million 0.29%
Total Liquid Assets CN¥20.00 Million 0.29%

Asset Resilience Insights

  • Limited Liquidity: Jiangsu Kanion Pharmaceutical Co Ltd maintains only 0.29% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Jiangsu Kanion Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jiangsu Kanion Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Alkem Laboratories Limited
NSE:ALKEM
Drug Manufacturers - Specialty & Generic 31.91%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Alkermes plc
F:8AK
Drug Manufacturers - Specialty & Generic 3.76%
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623
Drug Manufacturers - Specialty & Generic 4.97%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
Drug Manufacturers - Specialty & Generic 1.37%
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436
Drug Manufacturers - Specialty & Generic -2.56%

Annual Asset Resilience Ratio for Jiangsu Kanion Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual Asset Resilience Ratio data for Jiangsu Kanion Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.58% CN¥40.00 Million
≈ $5.85 Million
CN¥6.91 Billion
≈ $1.01 Billion
-5.88pp
2023-12-31 6.46% CN¥460.00 Million
≈ $67.31 Million
CN¥7.12 Billion
≈ $1.04 Billion
+3.96pp
2022-12-31 2.50% CN¥170.00 Million
≈ $24.88 Million
CN¥6.80 Billion
≈ $994.44 Million
-0.42pp
2021-12-31 2.92% CN¥176.00 Million
≈ $25.75 Million
CN¥6.02 Billion
≈ $880.63 Million
+2.85pp
2020-12-31 0.07% CN¥4.50 Million
≈ $658.49K
CN¥6.12 Billion
≈ $895.33 Million
+0.06pp
2019-12-31 0.01% CN¥800.00K
≈ $117.07K
CN¥6.11 Billion
≈ $894.21 Million
+0.00pp
2018-12-31 0.01% CN¥614.58K
≈ $89.93K
CN¥5.60 Billion
≈ $819.89 Million
-0.21pp
2015-12-31 0.22% CN¥9.30 Million
≈ $1.36 Million
CN¥4.30 Billion
≈ $629.88 Million
+0.18pp
2011-12-31 0.04% CN¥1.00 Million
≈ $146.33K
CN¥2.58 Billion
≈ $377.74 Million
--
pp = percentage points

About Jiangsu Kanion Pharmaceutical Co Ltd

SHG:600557 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.04 Billion
CN¥7.12 Billion CNY
Market Cap Rank
#8718 Global
#2091 in China
Share Price
CN¥12.57
Change (1 day)
-1.95%
52-Week Range
CN¥10.87 - CN¥19.83
All Time High
CN¥33.10
About

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 a… Read more